Lydia M. Goode v. HHS - tetanus, transverse myelitis (2023)
Case summary [AI summaries can sometimes make mistakes]
Lydia M. Goode filed a petition for vaccine compensation on May 3, 2021, alleging that she developed transverse myelitis as a result of receiving a tetanus vaccine on June 13, 2018.
The respondent, the Secretary of Health and Human Services, denied that the vaccine caused her alleged injury or current disabilities. Despite maintaining their respective positions, the parties reached a stipulation to settle the case.
The stipulation provided for a lump sum payment of $86,775.00 to Lydia M. Goode, representing compensation for all damages available under the National Vaccine Injury Compensation Program.
Special Master Thomas L. Gowen issued a decision on November 7, 2023, entering judgment in accordance with the terms of the stipulation.
The public decision does not describe the specific onset of symptoms, medical examinations, treatments, or expert testimony. Petitioner was represented by Leigh Finfer of Muller Brazil, LLP, and respondent was represented by Emily Manoso of the U.S.
Department of Justice.
Theory of causation
Petitioner Lydia M. Goode alleged that a tetanus vaccine administered on June 13, 2018, caused her to develop transverse myelitis. Respondent denied causation. The parties reached a stipulation for settlement, agreeing to an award of $86,775.00. Special Master Thomas L. Gowen issued a decision on November 7, 2023, entering judgment based on the stipulation. The public decision does not specify whether the theory of causation was Table or Off-Table, nor does it detail any medical experts, specific medical evidence, or the mechanism of injury. Petitioner's counsel was Leigh Finfer, and respondent's counsel was Emily Manoso.
Source PDFs
USCOURTS-cofc-1_21-vv-01307